MedTrace Logo

High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP

NCT02312362 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2014-12-09

No results posted yet for this study

Summary

Objective:

To compare intraocular pressure lowering effect of combined sclerotomy ab interno with phacoemulsification and phacoemulsification alone, in primary or secondary open angle glaucoma patients.

Study design:

Prospective, randomized, case- control interventional surgical trial

Conditions

Interventions

PROCEDURE

Combined sclerotomy ab interno and phaco

PROCEDURE

Phacoemulsification with IOL implantation

Sponsors & Collaborators

  • University of Geneva, Switzerland

    collaborator OTHER

  • Oertli Instrumente AG

    lead INDUSTRY

Principal Investigators

  • Farhad Hafezi, MD, PhD · University of Geneva, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-06-30
Completion
2016-12-31

Countries

  • Egypt
  • Germany
  • India
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02312362 on ClinicalTrials.gov